Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 29, 2009, the Board of Directors of Progenics Pharmaceuticals, Inc. elected Peter J. Crowley as a member of the Company's Board of Directors. He will serve as a director, subject to his earlier resignation or removal, until the Company's 2009 annual meeting of stockholders and the election and qualification of his successor. Mr. Crowley will also serve as a member of the Audit Committee of the Board of Directors. Mr. Crowley received a grant of 25,000 ten-year non-qualified stock options, vesting ratably over five years, under the Company's 2005 Stock Incentive Plan, the terms of which are described in the Company's Annual Report on Form 10-K for the year ended December 31, 2007, and will be compensated for his services as described in the discussion of director compensation in the Company's definitive proxy statement for its 2008 annual meeting of stockholders. The stock options have an exercise price of $7.45 per share, the closing price of the Company's common stock on January 29, 2009.

The Company's press release announcing the appointment of Mr. Crowley is attached as Exhibit 99.1, and the information contained therein is incorporated by reference into this Item 5.02 of this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

99.1 Press Release dated February 4, 2009.

---